The gauntlet has been thrown. The blue-light-hazard vs. blue-light-hype in the February issue of Opthalmology basically calls blue-light-blocking IOLs pure snake oil. We break down their arguments.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
